Parsons Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,718
| Closed | -$218K | – | 330 |
|
|
2019
Q4 | $218K | Buy |
+3,718
| New | +$218K | 0.02% | 328 |
|
|
2017
Q3 | – | Sell |
-4,674
| Closed | -$252K | – | 359 |
|
|
2017
Q2 | $252K | Hold |
4,674
| – | – | 0.03% | 318 |
|
|
2017
Q1 | $246K | Buy |
4,674
+240
| +5% | +$12.6K | 0.03% | 314 |
|
|
2016
Q4 | $213K | Buy |
4,434
+92
| +2% | +$4.42K | 0.03% | 316 |
|
|
2016
Q3 | $234K | Buy |
+4,342
| New | +$234K | 0.03% | 300 |
|
|
2015
Q3 | – | Sell |
-4,822
| Closed | -$251K | – | 340 |
|
|
2015
Q2 | $251K | Sell |
4,822
-40
| -0.8% | -$2.08K | 0.03% | 299 |
|
|
2015
Q1 | $280K | Buy |
4,862
+544
| +13% | +$31.3K | 0.04% | 272 |
|
|
2014
Q4 | $230K | Sell |
4,318
-896
| -17% | -$47.7K | 0.03% | 308 |
|
|
2014
Q3 | $299K | Sell |
5,214
-400
| -7% | -$22.9K | 0.04% | 278 |
|
|
2014
Q2 | $376K | Buy |
5,614
+160
| +3% | +$10.7K | 0.05% | 255 |
|
|
2014
Q1 | $364K | Sell |
5,454
-40
| -0.7% | -$2.67K | 0.05% | 259 |
|
|
2013
Q4 | $367K | Hold |
5,494
| – | – | 0.06% | 252 |
|
|
2013
Q3 | $345K | Buy |
5,494
+216
| +4% | +$13.6K | 0.06% | 242 |
|
|
2013
Q2 | $329K | Buy |
+5,278
| New | +$329K | 0.06% | 238 |
|